Very happy to announce that the sample size of the @_SOLTI @GroupeUnicancer RIBOLARIS phase II trial will be increased to 1,100 patients!
Ribolaris trial design: https://bit.ly/3JQ3iBO
https://classic.clinicaltrials.gov/ct2/show/NCT05296746
Very happy to lead this project together with Prof. Paul Cottu, Prof. @GavilKino and Prof. Thibault de La Motte Rouge